Researchers hone in on treatment targets for ovarian cancer
Instead of classifying tumors by where they are found inside the body – as breast, lung or ovarian cancer – researchers and clinicians are increasingly identifying cancers by their genetic signatures. With new insight into the biology of tumors, physicians can target cancer at the molecular level using smart drugs designed to attack tumor weaknesses. This strategy has proven effective for treating patients with various cancers, including those with advanced lung cancer and melanoma. Now, Mass General Cancer Center physician-scientists are applying those same principles to gynecologic oncology, redefining the way they view ovarian cancer.
U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.